Here we expand the knowledge of how proton-sensing GPCRs, in particular the Ovarian Cancer G-Protein Coupled Receptor 1, negatively regulate pathologic fibrotic signaling. This evidence concerns the gene CMKLR2 and ovarian carcinoma.